Perineal Hernia in Dogs: Why It Recurs and How Biologics Help

You’ve done the repair. The internal obturator was transposed, the sutures were placed under acceptable tension, and the dog recovered well. Eight months later the owner is back — the hernia is on the same side, the tissue looks worse than the first time, and you’re working in a field that has already been through one surgery. This is the perineal hernia recurrence scenario, and it happens in somewhere between 10 and 46% of dogs repaired with suture techniques alone.

Understanding why that recurrence rate is so high — and where biological scaffold augmentation changes the outcome — starts with the pathophysiology that makes perineal hernia anatomically different from every other hernia you repair.

Why Does Perineal Hernia Recur So Often After Suture Repair?

Perineal hernia is not a defect in a body wall that was intact and then failed. It’s the clinical consequence of progressive atrophy of the pelvic diaphragm muscles — specifically the levator ani and coccygeus — that were already compromised before the hernia became symptomatic. Biopsy specimens from affected dogs show neurogenic fiber atrophy on electromyography: the muscle fibers are not just stretched, they are denervated. The caudal rectal nerve, which supplies the pelvic diaphragm, is thought to be injured by chronic straining and intra-pelvic pressure, producing progressive neurogenic atrophy that predates and drives the structural failure.

When you repair a perineal hernia with standard appositional herniorrhaphy or internal obturator muscle transposition (IOMT), you are asking atrophied, often thin and friable muscle tissue to hold tension against the mechanical forces of straining, defecation, and intra-pelvic pressure — often in intact male dogs whose prostatic mass is still contributing to those forces. The failure mode is straightforward: sutures pull through atrophied tissue, or the repair holds initially but the underlying muscle continues to atrophy, eroding the structural integrity of the closure over months.

Breed predisposition reflects this biology directly. Welsh Corgis (particularly tail-docked individuals, in whom docking is thought to reduce pelvic diaphragm tone), Boston Terriers, and Boxers are overrepresented. Middle-aged to older intact male dogs constitute the vast majority of cases. Concurrent prostatic disease — benign hyperplasia, paraprostatic cysts — is present in a significant proportion and perpetuates the tenesmus that drives recurrence.

A 2025 retrospective study introduced an important nuance on castration timing: dogs castrated prior to herniorrhaphy were 4.4 times more likely to experience recurrence than dogs castrated concurrently at the time of repair. The protective effect attributed to castration appears to be specific to concurrent castration — not historical neutering. For intact dogs presenting with perineal hernia, this argues strongly for concurrent castration at the time of surgical repair, not as a staged procedure.

The Role of the Levator Ani and Coccygeus: When Muscle Atrophy Makes Closure Impossible

The pelvic diaphragm is a muscular sheet that closes the caudal pelvic outlet. In healthy dogs, the levator ani and coccygeus provide the structural floor that contains pelvic viscera. In perineal hernia patients, both muscles are variably atrophied — and the degree of atrophy at the time of surgery is one of the strongest predictors of repair success or failure.

When the internal obturator muscle is thin and friable at the time of transposition, the surgeon faces a fundamental tension problem: any suture placed to complete the repair is working against tissue that cannot reliably hold it. Standard herniorrhaphy is contraindicated when muscle atrophy is severe enough that primary apposition would require excessive tension on the external anal sphincter — the anchor point for the repair. Suture pull-through in this scenario is not a surgical technique failure; it is a tissue biology failure.

This is where the clinical decision about scaffold augmentation happens — not at the planning stage, but at the table, when the surgeon assesses the internal obturator and determines whether the muscle is robust enough to serve as the structural foundation for the repair. The inability to assess this preoperatively is one reason that having biological scaffold available for every perineal hernia repair is a reasonable standard, rather than planning augmentation only for known recurrences.

The bilateral presentation compounds the problem. Bilateral perineal hernia is common, and bilateral IOMT carries its own risks — particularly sciatic nerve injury if muscle transposition is too aggressive. Augmentation with a biological scaffold allows the surgeon to reduce the tension required on each individual muscle layer, decreasing both the risk of suture pull-through and the risk of iatrogenic nerve injury from over-mobilization.

What the Evidence Shows: SIS Scaffold Augmentation vs. Suture Repair Alone

Two published veterinary studies provide the specific outcome data for porcine SIS in perineal hernia repair.

Stoll and colleagues (2002, Veterinary Surgery) described the foundational proof-of-concept: 12 adult castrated male large-breed dogs with experimentally created bilateral pelvic diaphragm defects, with one side repaired using porcine SIS and the other with IOMT. The study concluded that SIS herniorrhaphy is viable as primary repair, as augmentation when the internal obturator muscle is too thin and friable to hold suture, and as a salvage procedure in cases of recurrence. This is the three-scenario framework that still defines BioSIS use in perineal hernia: primary repair, augmentation, and salvage.

Swieton and colleagues (2020, Canadian Veterinary Journal) provided the clinical outcome data: 14 animals (11 dogs and 3 cats), 21 total perineal hernias — 18 repaired with IOMT plus porcine SIS, 3 with porcine SIS alone. Recurrence rate was 14.3% (3 of 21 hernias) based on clinical signs, at a median of 176 days post-operatively. Median follow-up was 621 days — over 20 months — which is the longest follow-up window in any published perineal hernia series using a biological scaffold. Surgical site infection rate was 5.6% (1 of 21), consistent with BioSIS’s documented biocompatibility and infection resistance in a high-contamination anatomic location. The study concluded that both IOMT plus porcine SIS and porcine SIS alone are acceptable methods for perineal herniorrhaphy.

Put those numbers next to the suture-only data — 10 to 46% recurrence for standard herniorrhaphy, up to 36% for IOMT alone — and the argument for augmentation becomes clinical, not theoretical.

The mechanism behind the improved outcomes is what distinguishes BioSIS from synthetic mesh alternatives. Porcine SIS is an acellular extracellular matrix composed of collagen, glycosaminoglycans, proteoglycans, and growth factors that act as a three-dimensional scaffold for tissue repair and remodeling. Host fibroblasts infiltrate the scaffold, deposit organized collagen, and gradually replace the BioSIS material with native tissue. BioSIS completely resorbs, leaving behind only organized, healthy tissue — no permanent foreign material, no chronic foreign body reaction, and no risk of mesh migration or erosion into adjacent structures in a location that is routinely close to the rectum and bladder.

Three Clinical Scenarios Where Biological Scaffold Changes the Outcome

The thin internal obturator at the time of primary repair. The most common intraoperative decision point. An intact nine-year-old Boxer with a unilateral perineal hernia and prostatic enlargement undergoes IOMT. The internal obturator is found to be thin and friable at the time of transposition — adequate for mobilization, but unlikely to hold the tension of primary apposition without pull-through risk. BioSIS placed across the defect provides a scaffold for tissue ingrowth that does not depend on the atrophied muscle holding suture tension. Concurrent castration is performed. This is Stoll’s augmentation scenario — and it argues for having BioSIS on the surgical table for every perineal hernia repair, not just the ones identified as high-risk preoperatively.

The recurrent hernia with no remaining autologous options. A Welsh Corgi presents eight months after initial suture repair. The levator ani is nearly absent on the affected side; the internal obturator is partially scarred from the prior dissection. No reliable autologous flap is available. BioSIS as a standalone scaffold — used in 3 of 21 cases in the Swieton cohort — provides the structural platform for tissue regeneration where native repair is not possible. Because BioSIS resorbs and is replaced by the dog’s own tissue, the end result is organized native tissue filling the defect rather than a permanent implant that becomes a focus for chronic inflammation or future erosion.

First-time bilateral repair in a high-risk dog. A nine-year-old intact male Boston Terrier with bilateral perineal hernia and CT evidence of levator ani and coccygeus atrophy bilaterally. The surgeon plans bilateral IOMT with concurrent castration. Augmenting both sides with BioSIS at the time of primary repair addresses the documented weakness of IOMT alone — up to 36% recurrence in some series — by providing tension-free scaffold support across both defects simultaneously. The goal is to make the first repair the last repair, using the scaffold to compensate for the tissue quality deficit that suture alone cannot overcome.

For surgeons managing perineal hernia in dogs, the practical takeaway is straightforward: assess the internal obturator at the time of surgery, have BioSIS available for every case, and set the threshold for augmentation low — not just for recurrences or salvage repairs, but for any primary repair where muscle quality creates concern about suture pull-through. The published outcomes support augmentation as a standard addition to IOMT, not as a rescue technique reserved for the cases that have already failed once.

Learn more about BioSIS ECM for soft tissue repair at RethinkHealing.com.

Sources

1. Stoll MR, et al. The use of porcine small intestinal submucosa as a biomaterial for perineal herniorrhaphy in the dog. Veterinary Surgery. 2002;31(4):379–390.
2. Swieton N, et al. Retrospective evaluation on the outcome of perineal herniorrhaphy augmented with porcine small intestinal submucosa in dogs and cats. Can Vet J. 2020;61(6):629–637.
3. Perineal hernia recurrence risk factors — neutering timing. PubMed. 2025.
4. Retrospective evaluation: sacroischial sling vs. IOMT vs. traditional repair in 87 dogs. PMC. 2025.
5. Retrospective analysis of cone-shaped polypropylene mesh for perineal herniorrhaphy, 22 dogs. Frontiers Vet Sci. 2023.
6. American College of Veterinary Surgeons. Perineal Hernias overview.
7. Merck Veterinary Manual. Perineal Hernia in Dogs.